vimarsana.com

Latest Breaking News On - Medytox settlement agreements - Page 3 : vimarsana.com

Evolus Appoints Tomoko Yamagishi-Dressler as Chief Marketing Officer

Evolus Unveils New Branding for Flagship Product Jeuveau® to Reflect Growing and Evolving Consumers

Evolus Unveils New Branding for Flagship Product Jeuveau® to Reflect Growing and Evolving Consumers
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Evolus Reports Second Quarter 2023 Results and Provides Business Update

Q2 2023 Net Revenue of $49.3 Million, Up 33% from Q2 2022Raises Full-Year 2023 Net Revenue Guidance to $185 to $195 MillionOn Track to Achieving Sustained Profitability with Existing Cash NEWPORT BEACH, Calif. (BUSINESS WIRE) Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aes.

Evolus Raises Full-Year Revenue Guidance on Record Second Quarter 2023 Revenue

Evolus Raises Full-Year Revenue Guidance on Record Second Quarter 2023 Revenue
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Evolus Launches Nuceiva (botulinum toxin type A) in Italy

Evolus Launches Nuceiva (botulinum toxin type A) in Italy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.